Effect Of Takra Haritaki And Palashadi Yavagu In Reducing Signs And Symptoms Of Grahani Roga (Irritable Bowel Syndrome)

Efficacy Of Takra Haritaki And Palashadi Yavagu In The Management Of Grahani Roga (Irritable Bowel Syndrome) - An Open Label Single Arm Trial - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064412

Enrollment

Registered

2024-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: A)IBD-10-CM Code IBD 2024 ICD-10-CM Diagnosis Code K58.90 B)Age: 21-60 Years C)Gender-Both Males & Females D)Patients Having Pratyatma Lakshana Of Grahani Roga Especially – 1)Atisrushtam Or Ativibadhham Or Atidravam Malapravritti (Altered Bowel Habits) With Or Without Other Symptoms (Trushna, Arochaaka, Vairasya, Praseka, Tamaka, Shoona Pada, Shoona Kara, Asthi-Parva Ruja, Chhardi, Jwara, Louha-Ama-Gandhi Tiktamlodgar) & 2)The Patients Who Are Diagnosed With IBS According To Standard Rome Iv Criteria. E)Willing To Give Written Informed Consent.

Exclusion criteria

Exclusion criteria: 1)Previously Diagnosed Cases And History Of Ulcerative Colitis, Crohn’s Disease, Gastric Ulcerations, Intestinal Tuberculosis And Other Inflammatory Bowel Conditions. 2)Mixed Infection With Parasites Such As Round Worms, Hook Worms, & Lactose Intolerance Patients. 3)Patients With Evidence Of Malignancy. 4)Patents With Uncontrolled Diabetes Mellitus, Poorly Controlled Hypertension And Any Other Autoimmune Disorders. 5)Abuse Of Drug Or Alcohol. 6)Presence Of Other Somatic Or Mental Disorder Requiring Medication. 7)Patients On Prolonged Medication With Nsaids, Analgesics Or Any Other Drugs That May Have An Influence On The Outcome Of The Study. 8)Pregnant & Lactating Women.

Design outcomes

Primary

Measure	Time frame
70% Reduction In Signs And Symptoms Of Grahani Roga As Well IBS Severity Score Scale(IBS SSS).Timepoint: Baseline 15th Day 3oth Day 60th Day	—

Secondary

Measure	Time frame
To Improve The Quality Of Life. Timepoint: Baseline 30th Day 60th Day	—

Countries

India

Contacts

Public ContactDr Madeeha

All India Institute Of Ayurveda

drvghuddar@gmail.com9986697942

Outcome results